BebulinVH (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Bebulin drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | COAGULATION FACTOR IX HUMAN |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2011-03-16 |
END MARKETING DATE: | 0000-00-00 |
Bebulin VH HUMAN PRESCRIPTION DRUG Details:
Item Description | Bebulin VH from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2011-03-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64193-244_527b44a6-f9e2-4eae-8f68-6b4134465196 |
PRODUCT NDC: | 64193-244 |
APPLICATION NUMBER: | BLA103112 |